could soon be eligible for the vaccine, but, first, the shot must go through a rigorous authorization process that is taking a different path than the vaccines that came before. here to explain, u.s. surgeon general vivek murthy. what is curious about this is that i know there are millions of parents, including yourself, you have kids in the age range, waiting for this vaccine to be authorized, but the data hasn t shown it to be effective. so you re waiting for something that hasn t been proven to work? john, i m glad you asked about this. you re right, i m one of those millions of parents who has a child under 5 and i am eager for her to have a vaccine that is both safe and effective for her. let me tell you what we know and what we don t know right now. we do not know yet if this vaccine is going to be safe and effective for children under 5. that s exactly why the fda is beginning a process of rigorous review and that s going to be a transparent process where the